Tag Archives: Suraj Kalia

Analysts Are Bullish on These Healthcare Stocks: Titan Medical Inc (TMDI), Clearside Biomedical (CLSD)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Titan Medical Inc (TMDI – Research Report) and Clearside Biomedical (CLSD – Research Report) with bullish sentiments. Titan Medical Inc (TMDI) In

Northland Securities Sticks to Their Hold Rating for Obalon Therapeutics Inc (OBLN)

Northland Securities analyst Suraj Kalia maintained a Hold rating on Obalon Therapeutics Inc (OBLN – Research Report) today and set a price target of $1. The company’s shares closed yesterday at $0.66, close to its 52-week low of $0.37. Kalia

Intersect ENT (XENT) Receives a Hold from Northland Securities

Northland Securities analyst Suraj Kalia maintained a Hold rating on Intersect ENT (XENT – Research Report) today and set a price target of $20. The company’s shares closed yesterday at $21.10, close to its 52-week low of $20.80. Kalia said:

BioLife Solutions (BLFS) Gets a Buy Rating from Northland Securities

In a report released today, Suraj Kalia from Northland Securities maintained a Buy rating on BioLife Solutions (BLFS – Research Report), with a price target of $18. The company’s shares opened today at $17.94. According to TipRanks.com, Kalia is a

Northland Securities Keeps Their Hold Rating on Medtronic (MDT)

Northland Securities analyst Suraj Kalia maintained a Hold rating on Medtronic (MDT – Research Report) today and set a price target of $100. The company’s shares closed yesterday at $98.75, close to its 52-week high of $100.15. According to TipRanks.com,

Northland Securities Sticks to Its Hold Rating for Insulet Corp (PODD)

In a report released today, Suraj Kalia from Northland Securities maintained a Hold rating on Insulet Corp (PODD – Research Report), with a price target of $100. The company’s shares closed on Friday at $111.41, close to its 52-week high